Skip to main content
Clinical Trials/IRCT20240515061806N1
IRCT20240515061806N1RecruitingPhase 2

Comparison of adjuvant tadalafil and tamsulosin with tamsulosin alone in patients undergoing extracorporeal shockwave lithotripsy of renal stones

Kerman University of Medical Sciences0 sites160 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
160

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Patients older than 18 years
  • Having stones with a size between 5 and 20 mm in the kidney and proximal ureter

Exclusion Criteria

  • Having coagulation disorders
  • Creatinine clearance below 50 ml/min
  • Liver dysfunction
  • Urgent surgery is needed to remove stone blockage
  • Presence of positive urine culture
  • Patients with simultaneous unilateral or bilateral ureteral stones
  • The distance between the stone and the skin is more than 12 cm
  • History of previous unsuccessful extracorporeal lithotripsy
  • Use of nitroglycerin and netirocanthine
  • Lack of consent to participate in the study
  • Systolic blood pressure below 90 mm Hg at the time of treatment initiation
  • History of cataract
  • History of hypersensitivity after taking tamsulosin or tadalafil
  • History of back ache
  • History of Severe digestive disorders after treatment
  • History of priapism

Investigators

Similar Trials